24 min listen
Therapeutics Thursday (SCSS): Nanomedicines in clinical therapeutics: decades of progress but still evolving (Part 2)
FromASHPOfficial
Therapeutics Thursday (SCSS): Nanomedicines in clinical therapeutics: decades of progress but still evolving (Part 2)
FromASHPOfficial
ratings:
Length:
24 minutes
Released:
Apr 12, 2023
Format:
Podcast episode
Description
The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. In this second podcast on nanomedicines, pharmacists will be provided with examples of nanomedicines, their challenges, formulary considerations, and future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Released:
Apr 12, 2023
Format:
Podcast episode
Titles in the series (100)
From the Frontline of COVID-19: Clinician Perspectives on the impact of pharmacogenetics on treating patients with coronavirus: The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have ... by ASHPOfficial